Skip to main content

Table 2 The univariate analysis for total cost, OOP, reimbursement, and reimbursement rate of children with leukemia

From: Disparities in economic burden for children with leukemia insured by resident basic medical insurance: evidence from real-world data 2015–2019 in Guangdong, China

Variable Code Total Cost (CNY) OOP (CNY) Reimbursement (CNY) RR (%)
Median IQR Median IQR Median IQR Median IQR
Disease Type ALL 218,084.7 141,338.0–312,535.4 165,601.3 101,462.5–243,743.3 41,378.19 0.00–100,648.6 23.77 0.00–37.51
AML 301,265.2 218,178.0–415,918.3 224,771.8 153,500.4–296,861.8 87,791.30 0.00–165,320.2 26.97 0.00–43.59
Transplantation 535,881.1 424,825.7–783,175.1 398,933.7 237,443.5–536,682.6 162,134.7 0.00–371,971.7 29.18 0.00–56.76
P value *** *** *** ***
Insurance subtype Guangzhou RBMI 276,519.6 164,781.8–424,408.5 172,992 107,911.7–294,540.2 95,001.67 46,119.94–144,048.6 36.02 29.56–43.01
GD-contracted 275,138.1 178,242.0–413,903.0 180,306.6 108,787.0–265,812.9 91,881.23 44,683.79–161,344.2 35.16 23.51–46.50
GD-uncontracted 165,241.0 78,184.73–224,379.1 165,241.0 78,184.73–224,379.1 0 0.00–0.00 0 0.00–0.00
Other-contracted 273,699.3 191,074.4–348,430.8 198,347.4 159,018.7–253,269.8 64,180.55 36,478.73–102,633.9 23.08 13.16–34.32
Other-uncontracted 251,090.2 164,543.3–310,643.8 251,090.2 164,543.3–310,643.8 0 0.00–0.00 0 0.00–0.00
OOP 177,433.7 107,366.9–273,631.8 177,433.7 107,366.9–273,631.8 0 0.00–0.00 0 0.00–0.00
P value *** *** *** ***
Year 2015 103,381.9 60,223.97–188,093.9 82,487.89 37,817.86–144,893.0 0.00 0.00–38,610.20 0.00 0.00–36.44
2016 90,205.78 27,515.77–153,661.0 59,752.63 21,198.28–132,200.6 0.00 0.00–31,896.13 0.00 0.00–37.98
2017 85,075.54 15,820.08–174,135.1 54,219.21 13,373.37–136,003.3 1840.77 0.00–48,230.88 14.69 0.00–37.03
2018 82,765.10 14,040.39–202,800.7 61,490.79 10,386.24–148,066.5 5274.70 0.00–60,622.59 24.98 0.00–39.17
2019 55,551.60 11,747.07–152,260.7 40,780.51 8834.24–114,992.2 6311.06 0.00–40,160.43 24.89 0.00–36.68
P value ** *** *** ***
Age 0–5 220,654.9 145,597.8–303,492.5 171,986.8 106,132.7–246,369.6 38,820.03 0.00–94,410.15 22.73 0.00–36.99
6–10 244,457.1 156,938.0–388,577.1 179,391.5 115,559.3–273,534.0 52,122.70 0.00–116,160.6 19.87 0.00–42.12
11–15 333,470.6 198,986.3–536,133.8 227,305.0 144,895.5–318,728.3 94,356.12 0.00–201,191.5 29.49 0.00–48.85
P-value *** *** *** *
  1. Transplantation, the AML patients who received transplantation
  2. CNY Chinese Yuan, OOP out-of-pocket payment, ALL acute lymphoblastic leukemia, AML acute myeloid leukemia
  3. * p < 0.05, ** p < 0.01, *** p < 0.001, significance test by Wilcoxon Test